Atara Biotherapeutics: Q1 Earnings Snapshot

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Thursday reported first-quarter net income of $38 million, after reporting a loss in the same period a year earlier.

The Thousand Oaks, California-based company said it had profit of $3.50 per share.

The drug developer posted revenue of $98.1 million in the period.

Atara Biotherapeutics shares have declined 50% since the beginning of the year. The stock has decreased 56% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA

Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up